DENTSPLY SIRONA Inc. (XRAY) - What Are Researchers Thinking About This Stock?

Key Points

• Analysts maintain a “Hold” consensus on DENTSPLY SIRONA, with three sell, eight hold and three buy ratings. The average 12-month price target is $12.92, though several brokerages recently lowered their targets.
• Institutional investors own 95.7% of the company’s shares, with BlackRock and several other funds establishing or increasing positions during the second quarter.
• The stock opened at $9.08, near its 52-week low of $8.32. DENTSPLY SIRONA exceeded quarterly earnings and revenue estimates, but revenue declined 4.1% year over year and the company reported a negative net margin.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) have received a consensus recommendation of "Hold" from the fourteen ratings firms that are presently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $12.92.

A number of brokerages have recently issued reports on XRAY. BMO Capital Markets cut their price target on DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating on the stock in a report on Thursday, September 17th. Barclays boosted their price target on DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an "underweight" rating in a research report on Monday, August 24th. Barrington Research set a $15.00 price objective on DENTSPLY SIRONA in a research note on Monday, August 10th. Piper Sandler dropped their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a "neutral" rating on the stock in a research report on Friday, October 9th. Finally, Leerink Partners dropped their price objective on DENTSPLY SIRONA from $14.00 to $10.00 and set a "market perform" rating on the stock in a research report on Wednesday, October 14th.

Institutional Trading of DENTSPLY SIRONA

Several hedge funds have recently modified their holdings of the company. BlackRock Inc. purchased a new stake in DENTSPLY SIRONA in the second quarter valued at about $283,405,000. Paradigm Capital Management Inc. NY acquired a new stake in DENTSPLY SIRONA in the second quarter worth about $39,775,000. The Manufacturers Life Insurance Company acquired a new stake in DENTSPLY SIRONA in the second quarter worth about $1,956,000. Bank of New York Mellon Corp purchased a new stake in shares of DENTSPLY SIRONA during the second quarter worth about $16,408,000. Finally, Edmond DE Rothschild Holding S.A. purchased a new stake in shares of DENTSPLY SIRONA during the second quarter worth about $47,780,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Price Performance

Shares of XRAY opened at $9.08 on Thursday. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63. The company has a 50 day moving average price of $9.95 and a 200-day moving average price of $10.97. DENTSPLY SIRONA has a fifty-two week low of $8.32 and a fifty-two week high of $14.76. The stock has a market capitalization of $1.81 billion, a PE ratio of -3.30, a PEG ratio of 1.13 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.17. The company had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. DENTSPLY SIRONA's revenue for the quarter was down 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Equities analysts predict that DENTSPLY SIRONA will post 1.39 earnings per share for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.